...
首页> 外文期刊>Vaccine >Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes
【24h】

Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes

机译:使用新型稳定的茎纳米颗粒探针测量人血清中的流感血凝素(HA)茎特异性依赖性细胞细胞毒性(ADCC)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Generating vaccine that confers a complete protection is a major goal in designing a universal influenza vaccine. Currently, there is a considerable interest in the broadly neutralizing antibodies (bnAb) targeting the conserved HA stem region. These antibodies have been shown to activate cellular immune responses, such as ADCC, in addition to their neutralization activity. We had previously demonstrated that immunization with H1-based stabilized stem (SS) nanoparticles (np) protects against heterosubtypic lethal H5N1 challenge, despite the absence of detectable neutralizing activity. Utilizing these novel SS probes to develop an ADCC assay would help in understanding the mechanism of action of stem-specific antibodies, as well as evaluating future influenza vaccines.
机译:背景:产生赋予完全保护的疫苗是设计通用流感疫苗的主要目标。 目前,对靶向保守的HA茎区的宽度中和抗体(BNAB)存在相当大的兴趣。 除了中和活性之外,已经显示这些抗体以激活细胞免疫应答,例如ADCC。 尽管没有可检测的中和活性,我们以前证明使用基于H1的稳定性茎(SS)纳米颗粒(NP)免疫免疫致致死H5N1攻击。 利用这些新的SS探针开发ADCC测定将有助于理解茎特异性抗体的作用机制,以及评估未来流感疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号